162 related articles for article (PubMed ID: 22556352)
21. Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis.
Ruiz-Ballesteros E; Mollejo M; Rodriguez A; Camacho FI; Algara P; Martinez N; Pollán M; Sanchez-Aguilera A; Menarguez J; Campo E; Martinez P; Mateo M; Piris MA
Blood; 2005 Sep; 106(5):1831-8. PubMed ID: 15914563
[TBL] [Abstract][Full Text] [Related]
22. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.
Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A
Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147
[No Abstract] [Full Text] [Related]
23. Clinical and diagnostic relevance of
Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
[No Abstract] [Full Text] [Related]
24. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings.
Behdad A; Bailey NG
Arch Pathol Lab Med; 2014 Oct; 138(10):1295-301. PubMed ID: 25268192
[TBL] [Abstract][Full Text] [Related]
25. Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.
Caccuri F; Muraro E; Gloghini A; Turriziani O; Riminucci M; Giagulli C; Mastorci K; Fae' DA; Fiorentini S; Caruso A; Carbone A; Dolcetti R
Hematol Oncol; 2019 Apr; 37(2):176-184. PubMed ID: 30261551
[TBL] [Abstract][Full Text] [Related]
26. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
[TBL] [Abstract][Full Text] [Related]
27. The Krüppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma.
Piva R; Deaglio S; Famà R; Buonincontri R; Scarfò I; Bruscaggin A; Mereu E; Serra S; Spina V; Brusa D; Garaffo G; Monti S; Dal Bo M; Marasca R; Arcaini L; Neri A; Gattei V; Paulli M; Tiacci E; Bertoni F; Pileri SA; Foà R; Inghirami G; Gaidano G; Rossi D
Leukemia; 2015 Feb; 29(2):503-7. PubMed ID: 25283840
[No Abstract] [Full Text] [Related]
28. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.
Remstein ED; Law M; Mollejo M; Piris MA; Kurtin PJ; Dogan A
Leukemia; 2008 Jun; 22(6):1268-72. PubMed ID: 17989713
[No Abstract] [Full Text] [Related]
30. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide DNA profiling identifies clonal heterogeneity in marginal zone lymphomas.
Mian M; Kwee I; Rinaldi A; Ponzoni M; Bhagat G; Rossi D; Arcaini L; Gascoyne RD; Mollejo M; Baldini L; Thieblemont C; Gaidano G; Zucca E; Bertoni F
Br J Haematol; 2014 Mar; 164(6):896-9. PubMed ID: 24329863
[No Abstract] [Full Text] [Related]
32. Tissue proteomics of splenic marginal zone lymphoma.
Polati R; Brandi J; Dalai I; Zamò A; Cecconi D
Electrophoresis; 2015 Jul; 36(14):1612-21. PubMed ID: 25873066
[TBL] [Abstract][Full Text] [Related]
33. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
[TBL] [Abstract][Full Text] [Related]
34. Splenic marginal zone lymphoma: hydra with many heads?
Arcaini L; Paulli M
Haematologica; 2010 Apr; 95(4):534-7. PubMed ID: 20378575
[No Abstract] [Full Text] [Related]
35. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics.
Robles EF; Mena-Varas M; Barrio L; Merino-Cortes SV; Balogh P; Du MQ; Akasaka T; Parker A; Roa S; Panizo C; Martin-Guerrero I; Siebert R; Segura V; Agirre X; Macri-Pellizeri L; Aldaz B; Vilas-Zornoza A; Zhang S; Moody S; Calasanz MJ; Tousseyn T; Broccardo C; Brousset P; Campos-Sanchez E; Cobaleda C; Sanchez-Garcia I; Fernandez-Luna JL; Garcia-Muñoz R; Pena E; Bellosillo B; Salar A; Baptista MJ; Hernandez-Rivas JM; Gonzalez M; Terol MJ; Climent J; Ferrandez A; Sagaert X; Melnick AM; Prosper F; Oscier DG; Carrasco YR; Dyer MJ; Martinez-Climent JA
Nat Commun; 2016 Jun; 7():11889. PubMed ID: 27297662
[TBL] [Abstract][Full Text] [Related]
36. Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.
Salido M; Martinez-Avilés L; Ademà V; Ferrer A; Espinet B; Garcia M; Salar A; Besses C; Florensa L; Serrano S; Bellosillo B; Solé F
Leuk Res; 2011 Mar; 35(3):e23-4. PubMed ID: 21087793
[No Abstract] [Full Text] [Related]
37. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
[TBL] [Abstract][Full Text] [Related]
38. Insight into the molecular pathogenesis of hairy cell leukaemia, hairy cell leukaemia variant and splenic marginal zone lymphoma, provided by the analysis of their IGH rearrangements and somatic hypermutation patterns.
Hockley SL; Giannouli S; Morilla A; Wotherspoon A; Morgan GJ; Matutes E; Gonzalez D
Br J Haematol; 2010 Feb; 148(4):666-9. PubMed ID: 19863540
[No Abstract] [Full Text] [Related]
39. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation in lymphoma: an opportunity?
Ansell SM
Blood; 2015 Mar; 125(12):1848-9. PubMed ID: 25792729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
